ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986

Alternative Medicine: Testing The Boundaries Of Science

May 15, 1998

Obituaries: Paul Carbone; John Eisenberg; Paul Grotzinger

March 15, 2002

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014